Goodwin Procter advised the Special Committee of Zuora and Freshfields US advised Zuora, Simpson Thacher & Bartlett advised Silver Lake, Dechert advised GIC, Sullivan & Cromwell...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Samsung Display Co., Ltd on the transaction, while White & Case and Goodwin Procter advised eMagin. Samsung Display Co., Ltd, a subsidiary of Samsung...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
You must be a Standard 1 Year member to access this content.
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, Fried Frank and Appleby advised LumiraDx Limited on the deal, while Sidley Austin LLP acted for CA Healthcare Acquisition Corp. LumiraDx Limited announced its...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Markforged on the deal, while Cadwalader advised One.Markforged announced its definitive agreement to merge with One (NYSE: AONE), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Alpha Healthcare Acquisition Corp. on the deal. Covington & Burling LLP advised Humacyte, Inc. on the deal.Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC)...
You must be a Standard 1 Year member to access this content.
